# Title
Regioselective O
and O
stereoselective O
metabolism O
of O
ibuprofen B-Chemical
by O
human B-Species
cytochrome O
P450 O
2C. O

# Abstract
The O
cytochrome O
P450s O
responsible O
for O
the O
regio- O
and O
stereoselectivity O
in O
the O
2- O
and O
3-hydroxylation O
of O
the O
chiral O
non-steroidal O
antiinflammatory O
drug O
ibuprofen B-Chemical
were O
characterized O
in O
human B-Species
liver O
microsomes. O
The O
rates O
of O
formation O
of O
both O
the O
2- O
and O
3-hydroxy O
metabolites O
exhibited O
monophasic O
(N O
= O
2; O
N O
is O
the O
number O
of O
microsomal O
preparations) O
and O
biphasic O
(N O
= O
2) O
substrate O
concentration O
dependence O
for O
both O
enantiomers O
of O
ibuprofen. B-Chemical
The O
high O
affinity O
enzyme O
class O
parameters O
for O
S-ibuprofen B-Chemical
(N O
= O
4) O
were: O
2-hydroxylation, O
Vmax O
= O
566 O
+ O
- O
213 O
pmol O
min O
mg, O
Km O
= O
38 O
+ O
- O
13 O
microM; O
3-hydroxylation, O
Vmax O
= O
892 O
+ O
- O
630 O
pmol O
min O
mg, O
Km O
= O
21 O
+ O
- O
6 O
microM. O
For O
R-ibuprofen, B-Chemical
the O
corresponding O
parameters O
were: O
2-hydroxylation, O
Vmax O
= O
510 O
+ O
- O
117 O
pmol O
min O
mg, O
Km O
= O
47 O
+ O
- O
20 O
microM; O
3-hydroxylation, O
Vmax O
= O
593 O
+ O
- O
113 O
pmol O
min O
mg, O
Km O
= O
29 O
+ O
- O
8 O
microM. O
cDNA-expressed O
CYP2C9 B-Gene
(Arg B-Chemical
144 O
and O
Cys B-Chemical
144) O
favored O
S-2- O
and O
S-3-hydroxyibuprofen B-Chemical
formation, O
but O
CYP2C8 B-Gene
favored O
R-2-hydroxyibuprofen B-Chemical
formation. O
Sulfaphenazole, B-Chemical
retinol, B-Chemical
and O
arachidonic B-Chemical
acid I-Chemical
competitively O
inhibited O
the O
rate O
of O
formation O
of O
all O
hydroxyibuprofens; B-Chemical
Ki O
values O
(N O
= O
3) O
for O
sulfaphenazole B-Chemical
on O
the O
2- O
and O
3-hydroxylations O
of O
S-ibuprofen B-Chemical
were O
0.12 O
+ O
- O
0.05 O
and O
0.07 O
+ O
- O
0.04 O
and O
of O
R-ibuprofen B-Chemical
were O
0.11 O
+ O
- O
0.07 O
and O
0.06 O
+ O
- O
0.03 O
microM, O
respectively. O
Sulfaphenazole B-Chemical
also O
competitively O
inhibited O
ibuprofen B-Chemical
hydroxylation O
by O
cDNA-expressed O
CYP2C9 B-Gene
(Arg B-Chemical
144 O
and O
Cys B-Chemical
144) O
with O
Ki O
values O
in O
the O
range O
of O
0.05 O
to O
0.18 O
microM O
and O
CYP2C8 B-Gene
in O
the O
range O
of O
0.36 O
to O
0.55 O
microM. O
In O
a O
bank O
of O
14 O
human B-Species
liver O
microsome O
samples, O
significant O
correlations O
(r O
= O
0.72 O
to O
0.90; O
P O
< O
0.01) O
were O
observed O
between O
the O
rates O
of O
formation O
of O
all O
four O
hydroxyibuprofens, B-Chemical
and O
for O
each O
hydroxyibuprofen B-Chemical
and O
prototypical O
CYP2C8 B-Gene
9 I-Gene
biotransformations. O
The O
regio- O
and O
stereoselectivities O
observed O
in O
vitro O
were O
consistent O
with O
those O
noted O
in O
vivo. O
The O
relative O
levels O
of O
both O
CYP2C8 B-Gene
and O
CYP2C9 B-Gene
and O
the O
expression O
of O
the O
corresponding O
variants O
may O
influence O
the O
disposition O
of O
ibuprofen B-Chemical
in O
vivo. O